Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic fibrinogen to reduce bleeding during elective cesarean section
IRCT20120910010800N8Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Fibrinogen with Placebo (2 arms). Primary endpoints: Bleeding during surgery and Postoperative bleeding. Started Dec 2022; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20120910010800N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120910010800N8.